ATAI Life Sciences (DE:9VC)
XETRA:9VC
Holding DE:9VC?
Track your performance easily

ATAI Life Sciences (9VC) Financial Statements

4 Followers

ATAI Life Sciences Financial Overview

ATAI Life Sciences's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; ATAI Life Sciences is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is €-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 273.00K-$ 18.00K$ 87.00K$ 172.00K
Gross Profit$ 273.00K-$ 18.00K$ 87.00K$ 172.00K
EBIT$ -26.43M$ -25.70M$ -17.63M$ 44.53M$ -31.00M
EBITDA$ -26.25M$ -25.52M$ -17.53M$ 44.71M$ -30.83M
Net Income Common Stockholders$ -57.31M$ -26.71M$ -18.29M$ 44.28M$ -33.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.33M$ 18.87M$ 45.03M$ 76.49M$ 141.09M
Total Assets$ 215.78M$ 269.12M$ 293.48M$ 308.22M$ 253.59M
Total Debt$ 16.07M$ 16.05M$ 16.04M$ 16.26M$ 16.29M
Net Debt$ -3.26M$ -2.82M$ -29.00M$ -60.23M$ -124.81M
Total Liabilities$ 47.24M$ 45.86M$ 49.16M$ 39.71M$ 37.96M
Stockholders Equity$ 167.89M$ 222.54M$ 242.96M$ 266.28M$ 212.55M
Cash Flow-
Free Cash Flow$ -16.23M$ -22.57M$ -21.97M$ -18.43M$ -22.51M
Operating Cash Flow$ -16.23M$ -22.57M$ -21.96M$ -18.43M$ -22.54M
Investing Cash Flow$ 16.30M$ 11.47M$ -823.00K$ -46.48M$ -22.08M
Financing Cash Flow$ 326.00K-$ -8.46M-$ -100.00K
Currency in USD

ATAI Life Sciences Earnings and Revenue History

ATAI Life Sciences Debt to Assets

ATAI Life Sciences Cash Flow

ATAI Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis